Balancing act: EU trade policy review
Trade & Manufacturing
The EU’s new trade strategy unveiled last week has the ambition to guide Brussels’ trade policymaking for the next decade. But what is notable about it is the way that it actually struggles to set out a clear and unequivocal direction for policy. Instead, it tries to strike a difficult balance between two conflicting impulses on free trade and growing inward-looking…
The UK Supreme Court has issued its ruling on Uber – what next?
On Friday, the UK Supreme Court issued its long-awaited ruling on the employment status of Uber drivers. It concluded that Uber drivers are “workers”, a form of intermediary status in UK employment law which provides individuals with some, but not all the rights enjoyed by permanent employees, including minimum wage and paid holiday. The ruling was the latest and last in…
Rolling out the covid-19 vaccine in emerging markets
Global Macro Practice Lead Thomas Gratowski, and Senior Associates Isabelle Trick and Brigitta Kinadi examine how Asia and Sub-Saharan Africa are approaching covid-19 vaccines and look at how well different emerging markets are positioned to achieve vaccine targets. They also explore how countries have handled the transmission of cases and and when we might be able to…
US trade: same tools, used responsibly
Trade & Manufacturing
President Joe Biden’s initial actions on trade shows that President Trump’s trade legacy and his willingness to leverage national security powers to enact trade remedies is likely to prove stickier than many in the private sector would have hoped. So far, the key difference in the new administration’s approach has been largely rhetorical as President Biden positions…
The Politics of Life After Covid
Over the last few years, Global Counsel has convened a policy conference each January to look at the year ahead, taking a big theme and unpacking it. This year’s event was held fully online and focused on the politics of life after covid-19.
Maintaining innovation: clinical trials post-covid
Earlier this month, GC hosted a debate on the success and future of clinical trials in the UK. The UK’s profile as a global leader in life sciences has been enhanced by the covid-19 pandemic. Industry, the NHS and regulators collaborated effectively to be at the forefront of innovation in vaccines and treatments. The RECOVERY trial and its identification of dexamethasone…